Determination of Decision Limits for ACS:Systems Cardiac Troponin I
| Autor: | Graziella Bonetti, Francesca Stefini, Claudio Cuccia, Mauro Panteghini, Franca Pagani |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
medicine.medical_specialty
Cardiac troponin Clinical Biochemistry Myocardial Infarction Infarction Disease Sensitivity and Specificity Internal medicine Troponin I medicine Humans Myocardial infarction Decision level biology business.industry Myocardium Biochemistry (medical) Reproducibility of Results General Medicine medicine.disease Troponin Surgery ROC Curve Cardiology biology.protein business Cohort study |
| Zdroj: | Clinical Chemistry and Laboratory Medicine. 38 |
| ISSN: | 1434-6621 |
| DOI: | 10.1515/cclm.2000.176 |
| Popis: | The availability of specific markers of myocardial damage has focused attention on the decision limits to be used in clinical practice. These markers can be employed in the diagnosis of myocardial infarction and risk stratification in patients with acute coronary syndromes but no infarction. The measurement of troponin I was undertaken in two 60 patient cohorts with these disease classifications. The best decision level for patients with acute myocardial infarction was found to be 3.1 microg/l; for the detection of minimal myocardial damage the cut-off was equal to the detection limit of the method (0.2 microg/l). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|